Plain-English translation of NCT07223424 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether patients prefer receiving or — two immune-boosting medications used to treat advanced cancers — as injections under the skin instead of through an IV infusion into the arm. The study will ask you about your experience with both methods to understand which delivery method works better for patients like you.
Doctors developed these under-the-skin injections to make treatment easier and less burdensome for patients, but many hospitals and cancer centers are not using them yet. This study wants to formally ask patients which method they truly prefer, so that doctors can offer the best option for your care.
You likely qualify if…
You likely don't qualify if…
You will receive your immune therapy in two phases, each lasting about 3 treatment cycles. In one phase, you will receive the medication as injections under your skin; in the other phase, you will receive it through an IV infusion. The study team will ask you questions about your experience with both methods to understand which you prefer. You will also be monitored for how well the treatment works and any side effects you experience.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States